News & Updates
Filter by Specialty:
Low-dose semaglutide spurs MASLD regression in people with HIV
21 Mar 2024
byJairia Dela Cruz
Treatment with low-dose semaglutide helps reduce the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with HIV, according to data from the single-arm phase IIb ACTG A5371 trial.
Low-dose semaglutide spurs MASLD regression in people with HIV
21 Mar 2024Antidepressants improve cognition in people with late-life depression
19 Mar 2024
Use of antidepressant medication may lead to improvements in some areas of cognitive function, such as memory and learning, in individuals with late-life depression (LLD), a study has shown.
Antidepressants improve cognition in people with late-life depression
19 Mar 2024Dupilumab mends skin barrier in children with AD, but with caveat
19 Mar 2024
byStephen Padilla
Use of dupilumab results in normalization of stratum corneum (SC) lipids, which is responsible for skin barrier function, in children with atopic dermatitis (AD) within 1 to 2 months of treatment, according to a study presented at AAAAI 2024.